MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 302-79-4
Formula C20H28O2MW 300.4Research-use catalog entryCOA/SDS by request

Retinoic Acid

CAS Number: 302-79-4

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Supply options

Availability by request

Availability
Available by request
Documents
COA/SDS available on request
Shipping
Shipping reviewed before dispatch

Public pricing is not shown for this CAS. Submit an RFQ to confirm availability, documentation, and shipping review.

Loading RDKit molecule structure...
InChIKey: SHGAZHPCJJPHSC-YCNIQYBTSA-NC20H28O2 | MW 300.4

Chemical Absolute Identifiers

CAS Number

302-79-4

PubChem CID

444795

Molecular Formula

C20H28O2

Molecular Weight

300.4 g/mol

Exact Mass

300.20893

InChIKey

SHGAZHPCJJPHSC-YCNIQYBTSA-N

IUPAC Name

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid

SMILES String

CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C

Physical Properties

Appearance

All-trans-retinoic acid is a yellow to light-orange crystalline powder. (NTP, 1992)

Melting Point

178.89–182.22 °C

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

Retinoic Acid (CAS 302-79-4) is listed in the Advanced Chemicals portfolio, with molecular formula C20H28O2 and molecular weight 300. 40 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research building-block and synthetic chemistry workflows.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Natural Product ResearchSynthetic ChemistryResearch intermediateCustom synthesis building blockResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Retinoic acid receptor gamma (Homo sapiens) — 58 assays; Retinoic acid receptor alpha (Homo sapiens) — 58 assays; Nuclear receptor ROR-beta (Homo sapiens) — 5 assays; Retinoic acid receptor gamma (Mus musculus) — 5 assays; Retinoic acid receptor beta (Homo sapiens) — 63 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Retinoic acid receptor gamma

Homo sapiens · SINGLE PROTEIN · 58 qualifying assays · 37 documents · best pChEMBL 10.4

Experimental evidence source: ChEMBL

Retinoic acid receptor alpha

Homo sapiens · SINGLE PROTEIN · 58 qualifying assays · 36 documents · best pChEMBL 10

Experimental evidence source: ChEMBL

Nuclear receptor ROR-beta

Homo sapiens · SINGLE PROTEIN · 5 qualifying assays · 2 documents · best pChEMBL 9.82

Experimental evidence source: ChEMBL

Retinoic acid receptor gamma

Mus musculus · SINGLE PROTEIN · 5 qualifying assays · 5 documents · best pChEMBL 9.66

Experimental evidence source: ChEMBL

Retinoic acid receptor beta

Homo sapiens · SINGLE PROTEIN · 63 qualifying assays · 36 documents · best pChEMBL 9.4

Experimental evidence source: ChEMBL

Safety & Handling

Safety and handling reference content is available through documentation requests.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

Retinoic Acid

Names & Synonyms

tretinoinall-trans-Retinoic acidVitamin A acidtrans-Retinoic acidATRA
Show all synonyms
AberelEudynaRenovaDermairolall-trans-Vitamin A acidCordes vasRetin ATretin MAtralinall-trans-TretinoinRetionic acidall-trans-Vitamin A1 acidbeta-RaRetin-A MicroVitamin A1 acid, all-trans-
External Identifiers
EC NUMBER: 206-129-0DSSTOX SUBSTANCE ID: DTXSID7021239CHEMBL ID: CHEMBL38CHEBI ID: CHEBI:15367UNII: 5688UTC01RDRUGBANK ID: DB00755HMDB ID: HMDB0001852KEGG ID: C00777KEGG ID: D00094METABOLOMICS WORKBENCH ID: 29042NCI THESAURUS CODE: C68301NCI THESAURUS CODE: C900PHARMGKB ID: PA451746RXCUI: 10753WIKIDATA ID: Q29417
Experimental Spectrum References
13C NMR Spectra1H NMR SpectraATR-IR SpectraFTIR SpectraRaman SpectraUV Spectra
Literature & Patent References
DOI 10.1016/j.ejmech.2025.117236Synthesis and biological evaluation of novel pyrrolo[2,3-b]pyridine derivatives as potent GSK-3β inhibitors for treating Alzheimer's disease.PMID 39798400Synthesis and biological evaluation of novel pyrrolo[2,3-b]pyridine derivatives as potent GSK-3β inhibitors for treating Alzheimer's disease.DOI 10.1016/j.bmcl.2024.1296812-(3-Indolyl)acetamides and their oxazoline analogues: Anticancer SAR study.DOI 10.1016/j.ejmech.2024.116779Halogenated retinoid derivatives as dual RARα and RXRα modulators for treating acute promyelocytic leukemia cells.DOI 10.1016/j.isci.2024.108907Identification and evaluation of small-molecule inhibitors against the dNTPase SAMHD1 via a comprehensive screening funnelDOI 10.1021/acs.jmedchem.4c01412Re-Evaluating PIN1 as a Therapeutic Target in Oncology Using Neutral Inhibitors and PROTACs.DOI 10.1021/acs.jnatprod.4c00640Machine Learning Accelerates Screening of Osteoclast Differentiation Inhibitors from Natural Products.PMID 38318365Identification and evaluation of small-molecule inhibitors against the dNTPase SAMHD1 via a comprehensive screening funnel

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

FenretinideCAS 65646-68-6
Retinol PalmitateCAS 79-81-2

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 65646-68-6FenretinideCAS 79-81-2Retinol PalmitateCAS 21829-25-4NifedipineCAS 97-18-7BithionolCAS 112574-44-4NitrofurazoneCAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamateCAS 1005174-17-3(E)-3-(2-Propyl-6-(trifluoromethyl)pyridin-3-yl)acrylic acidCAS 1018125-49-92-(3-Cyclopropyl-6-ethyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acidCAS 1018128-07-8Isopropyl 4-chloro-2-methylquinoline-6-carboxylateCAS 1018142-22-76-cyclopropyl-1-(2,2-difluoroethyl)-3-methyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid

RFQ questions for CAS 302-79-4

What are the key identifiers for Retinoic Acid (CAS 302-79-4)?

Retinoic Acid is identified by CAS 302-79-4, with molecular formula C20H28O2, molecular weight 300.4, InChIKey SHGAZHPCJJPHSC-YCNIQYBTSA-N.

Does CAS 302-79-4 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Retinoic acid receptor gamma, Retinoic acid receptor alpha, Nuclear receptor ROR-beta, Retinoic acid receptor gamma, Retinoic acid receptor beta. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 302-79-4?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for Retinoic Acid?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 302-79-4 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.